These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 18401840

  • 21. Development of a scoring system for predicting the risk of preterm birth in women receiving cervical cerclage.
    Odibo AO, Farrell C, Macones GA, Berghella V.
    J Perinatol; 2003 Dec; 23(8):664-7. PubMed ID: 14647165
    [Abstract] [Full Text] [Related]

  • 22. Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011.
    Sibai BM, Istwan NB, Palmer B, Stanziano GJ.
    Am J Perinatol; 2012 Sep; 29(8):635-42. PubMed ID: 22576126
    [Abstract] [Full Text] [Related]

  • 23. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
    Rafael TJ, Mackeen AD, Berghella V.
    Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
    [Abstract] [Full Text] [Related]

  • 24. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO, Stamilio DM, Macones GA, Polsky D.
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [Abstract] [Full Text] [Related]

  • 25. 17 hydroxyprogesterone for the prevention of preterm delivery.
    Meis PJ, Society for Maternal-Fetal Medicine.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1128-35. PubMed ID: 15863556
    [Abstract] [Full Text] [Related]

  • 26. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.
    Berghella V, Figueroa D, Szychowski JM, Owen J, Hankins GD, Iams JD, Sheffield JS, Perez-Delboy A, Wing DA, Guzman ER, Vaginal Ultrasound Trial Consortium.
    Am J Obstet Gynecol; 2010 Apr; 202(4):351.e1-6. PubMed ID: 20350641
    [Abstract] [Full Text] [Related]

  • 27. What is the optimal gestational age for history-indicated cerclage placement?
    Suhag A, Seligman NS, Bianchi I, Berghella V.
    Am J Perinatol; 2010 Jun; 27(6):469-74. PubMed ID: 20119889
    [Abstract] [Full Text] [Related]

  • 28. Impact of 17P usage on NICU admissions in a managed medicaid population--a five-year review.
    Mason MV, Poole-Yaeger A, Krueger CR, House KM, Lucas B.
    Manag Care; 2010 Feb; 19(2):46-52. PubMed ID: 20550052
    [Abstract] [Full Text] [Related]

  • 29. A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix.
    Keeler SM, Kiefer D, Rochon M, Quinones JN, Novetsky AP, Rust O.
    J Perinat Med; 2009 Feb; 37(5):473-9. PubMed ID: 19492920
    [Abstract] [Full Text] [Related]

  • 30. Short cervical length after history-indicated cerclage: is a reinforcing cerclage beneficial?
    Baxter JK, Airoldi J, Berghella V.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1204-7. PubMed ID: 16157138
    [Abstract] [Full Text] [Related]

  • 31. 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery.
    Facchinetti F, Dante G, Venturini P, Paganelli S, Volpe A.
    Am J Perinatol; 2008 Sep; 25(8):503-6. PubMed ID: 18756431
    [Abstract] [Full Text] [Related]

  • 32. Uterine activity in patients with cervical cerclage.
    Robichaux AG, Stedman CM, Hamer C.
    Obstet Gynecol; 1990 Jul; 76(1 Suppl):63S-66S. PubMed ID: 2359583
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F, Vaccaro V.
    Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of double cervical cerclage in women with at least one previous pregnancy loss in the second trimester: a randomized controlled trial.
    Tsai YL, Lin YH, Chong KM, Huang LW, Hwang JL, Seow KM.
    J Obstet Gynaecol Res; 2009 Aug; 35(4):666-71. PubMed ID: 19751325
    [Abstract] [Full Text] [Related]

  • 35. The prediction of recurrent preterm birth in patients on 17-alpha-hydroxyprogesterone caproate using serial fetal fibronectin and cervical length.
    Romero J, Rebarber A, Saltzman DH, Schwartz R, Peress D, Fox NS.
    Am J Obstet Gynecol; 2012 Jul; 207(1):51.e1-5. PubMed ID: 22595378
    [Abstract] [Full Text] [Related]

  • 36. Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate.
    Szychowski JM, Berghella V, Owen J, Hankins G, Iams JD, Sheffield JS, Perez-Delboy A, Wing DA, Guzman ER, Vaginal Ultrasound Trial Consortium.
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2686-9. PubMed ID: 22889234
    [Abstract] [Full Text] [Related]

  • 37. Antepartum uterine contraction patterns in twin pregnancies with and without preterm labor and delivering before or after 36 weeks.
    Hernández AR, González-Quintero VH, Istwan N, Rhea D, Vázquez-Vera E, Flick AA, Stanziano G.
    Am J Obstet Gynecol; 2008 May; 198(5):e28-9. PubMed ID: 18068140
    [Abstract] [Full Text] [Related]

  • 38. Novel application of polypropylene sling: transvaginal cervicoisthmic cerclage in women with high risk of preterm delivery.
    Deffieux X, De Tayrac R, Louafi N, Gervaise A, Bonnet K, Frydman R, Fernandez H.
    J Minim Invasive Gynecol; 2006 May; 13(3):216-21. PubMed ID: 16698528
    [Abstract] [Full Text] [Related]

  • 39. Prophylactic cerclage in the management of triplet pregnancies.
    Rebarber A, Roman AS, Istwan N, Rhea D, Stanziano G.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1193-6. PubMed ID: 16157136
    [Abstract] [Full Text] [Related]

  • 40. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S.
    Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.